Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Acanthus ebracteatus*, commonly known as Holly Mangrove, is a medicinal mangrove species native to Southeast Asia and widely used in Thai traditional medicine. It is primarily utilized for the treatment of inflammatory skin conditions, wound healing, and as a neuroprotective agent. The therapeutic activity is attributed to various phytochemicals, including verbascoside (acteoside) and benzoxazolinone-type alkaloids. Research has demonstrated that extracts of *Acanthus ebracteatus* possess significant anti-inflammatory, antioxidant, and antimicrobial properties. In clinical and preclinical studies, it has been investigated as a topical treatment for atopic dermatitis, a component of combination therapies for acne vulgaris, and a potential treatment for androgenic alopecia due to its ability to inhibit 5-alpha reductase and promote dermal papilla cell proliferation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acanthus ebracteatus.